These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 37593894)
1. Aldosterone Antagonism Is More Effective at Reducing Blood Pressure and Excessive Renal ENaC Activity in AngII-Infused Female Rats Than in Males. Buncha V; Cherezova A; Alexander S; Baranovskaya I; Coleman KA; Cherian-Shaw M; Brands MW; Sullivan JC; O'Connor PM; Mamenko M Hypertension; 2023 Oct; 80(10):2196-2208. PubMed ID: 37593894 [TBL] [Abstract][Full Text] [Related]
2. Maintained ENaC trafficking in aldosterone-infused rats during mineralocorticoid and glucocorticoid receptor blockade. Nielsen J; Kwon TH; Frøkiaer J; Knepper MA; Nielsen S Am J Physiol Renal Physiol; 2007 Jan; 292(1):F382-94. PubMed ID: 16912064 [TBL] [Abstract][Full Text] [Related]
3. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease. Bovée DM; Uijl E; Severs D; Rubio-Beltrán E; van Veghel R; Maassen van den Brink A; Joles JA; Zietse R; Cuevas CA; Danser AHJ; Hoorn EJ Am J Physiol Renal Physiol; 2021 Apr; 320(4):F654-F668. PubMed ID: 33586496 [TBL] [Abstract][Full Text] [Related]
4. [Regulation of kidney on potassium balance and its clinical significance]. Xie QH; Hao CM Sheng Li Xue Bao; 2023 Apr; 75(2):216-230. PubMed ID: 37089096 [TBL] [Abstract][Full Text] [Related]
5. Electrolyte and transporter responses to angiotensin II induced hypertension in female and male rats and mice. Veiras LC; McFarlin BE; Ralph DL; Buncha V; Prescott J; Shirvani BS; McDonough JC; Ha D; Giani J; Gurley SB; Mamenko M; McDonough AA Acta Physiol (Oxf); 2020 May; 229(1):e13448. PubMed ID: 31994810 [TBL] [Abstract][Full Text] [Related]
6. Sodium transporter abundance profiling in kidney: effect of spironolactone. Nielsen J; Kwon TH; Masilamani S; Beutler K; Hager H; Nielsen S; Knepper MA Am J Physiol Renal Physiol; 2002 Nov; 283(5):F923-33. PubMed ID: 12372767 [TBL] [Abstract][Full Text] [Related]
7. Impact of Mineralocorticoid Receptor and Angiotensin II Type 1 Receptor Antagonism on Blood Pressure Regulation in Obese Zucker Rats: Role of Sex Differences. do Carmo JM; da Silva AA; Hall JE Am J Hypertens; 2021 Sep; 34(9):999-1005. PubMed ID: 33075125 [TBL] [Abstract][Full Text] [Related]
8. Albuminuria is associated with an increased prostasin in urine while aldosterone has no direct effect on urine and kidney tissue abundance of prostasin. Oxlund C; Kurt B; Schwarzensteiner I; Hansen MR; Stæhr M; Svenningsen P; Jacobsen IA; Hansen PB; Thuesen AD; Toft A; Hinrichs GR; Bistrup C; Jensen BL Pflugers Arch; 2017 Jun; 469(5-6):655-667. PubMed ID: 28233126 [TBL] [Abstract][Full Text] [Related]
14. The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism. Eudy RJ; Sahasrabudhe V; Sweeney K; Tugnait M; King-Ahmad A; Near K; Loria P; Banker ME; Piotrowski DW; Boustany-Kari CM J Transl Med; 2011 Oct; 9():180. PubMed ID: 22017794 [TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid Receptor Antagonists Cause Natriuresis in the Absence of Aldosterone. Maeoka Y; Su XT; Wang WH; Duan XP; Sharma A; Li N; Staub O; McCormick JA; Ellison DH Hypertension; 2022 Jul; 79(7):1423-1434. PubMed ID: 35506380 [TBL] [Abstract][Full Text] [Related]
16. Blood pressure responses to small doses of amiloride and spironolactone in normotensive subjects. Pratt JH; Eckert GJ; Newman S; Ambrosius WT Hypertension; 2001 Nov; 38(5):1124-9. PubMed ID: 11711509 [TBL] [Abstract][Full Text] [Related]
17. Intestinal Mineralocorticoid Receptor Contributes to Epithelial Sodium Channel-Mediated Intestinal Sodium Absorption and Blood Pressure Regulation. Nakamura T; Kurihara I; Kobayashi S; Yokota K; Murai-Takeda A; Mitsuishi Y; Morisaki M; Kohata N; Oshima Y; Minami Y; Shibata H; Itoh H J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29929989 [TBL] [Abstract][Full Text] [Related]
18. Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension. Xue B; Beltz TG; Yu Y; Guo F; Gomez-Sanchez CE; Hay M; Johnson AK Am J Physiol Heart Circ Physiol; 2011 Feb; 300(2):H555-64. PubMed ID: 21112947 [TBL] [Abstract][Full Text] [Related]
19. Lithium-induced NDI in rats is associated with loss of alpha-ENaC regulation by aldosterone in CCD. Nielsen J; Kwon TH; Frøkiaer J; Knepper MA; Nielsen S Am J Physiol Renal Physiol; 2006 May; 290(5):F1222-33. PubMed ID: 16332930 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist. Arai K; Homma T; Morikawa Y; Ubukata N; Tsuruoka H; Aoki K; Ishikawa H; Mizuno M; Sada T Eur J Pharmacol; 2015 Aug; 761():226-34. PubMed ID: 26073023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]